New Key Statistics Module, Z-Score and F-Score
OTCPK:AULSF Key Ratios
| Market Cap $ M | 53.81 |
| Enterprise Value $ M | 98.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.03 |
| Price/Sales | 0.01 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 246.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -2.57 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 26.90 |
| y-y EBITDA Growth Rate % | -85.10 |
| EV-to-EBIT | -35.60 |
| EV-to-EBITDA | -35.60 |
| PEG | -- |
| Shares Outstanding M | 512.58 |
| Net Margin (%) | -6.43 |
| Operating Margin % | -0.51 |
| Pre-tax Margin (%) | -1.95 |
| Quick Ratio | 1.13 |
| Current Ratio | 1.34 |
| ROA % (ttm) | -4.93 |
| ROE % (ttm) | -13.36 |
| ROIC % (ttm) | -0.62 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.42 |
AULSF Number of Guru Trades
AULSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:AULSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AULSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Austar Lifesciences Ltd Insider Transactions
No Available Data
News about OTCPK:AULSF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers